In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: GE HealthCare Technologies trades at $61.59, significantly below its PERT-weighted fair value of $128.94, indicating substantial upside potential. High-confidence DCF and P/E valuations align with this undervaluation, while Monte Carlo analysis shows low downside risk (2.9%) despite high volatility. Strong profitability contrasts with moderate growth, signaling a balanced risk-reward profile.